Procter & Gamble Health Limited — Financials & Forensics
Sector: Healthcare · NSE: PGHL · BSE: 500126 · ISIN: INE199A01012
01 Oct 2026
Add PGHL to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹1,009 Cr | ₹1,114 Cr | ₹1,230 Cr | ₹1,151 Cr | ₹1,408 Cr |
| EBITDA | ₹246 Cr | ₹268 Cr | ₹324 Cr | ₹306 Cr | ₹457 Cr |
| EBITDA margin | 24.4% | 24.1% | 26.4% | 26.6% | 32.4% |
| Profit after tax | ₹177 Cr | ₹193 Cr | ₹229 Cr | ₹201 Cr | ₹327 Cr |
Deeper analysis
Recent filings by Procter & Gamble Health Limited
-
Press Release
06 Aug 2026 · Financial Results
-
Outcome of Board Meeting.
06 Aug 2026 · Financial Results
Never miss a filing again
About Procter & Gamble Health Limited on Indian Stock Alerts
Indian Stock Alerts tracks Procter & Gamble Health Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.